|
Q3 2024
|
28 |
484,004 |
TRDA, ELVN, SKYE, ARTIVA BIOTHERAPEUTICS INC
|
13F-HR
|
11/14/2024 |
000110465924118921 |
|
Q2 2024
|
28 |
447,094 |
SKYE BIOSCIENCE INC, TRDA, ELVN, DNTH
|
13F-HR
|
8/14/2024 |
000110465924089661 |
|
Q1 2024
|
26 |
446,626 |
ELVN, TRDA, DNTH, MRUS
|
13F-HR
|
5/15/2024 |
000110465924061973 |
|
Q4 2023
|
25 |
376,980 |
ELVN, TRDA, PHVS, CLDX
|
13F-HR
|
2/14/2024 |
000110465924023676 |
|
Q3 2023
|
26 |
347,538 |
ELVN, TRDA, IRON, DNTH
|
13F-HR
|
11/14/2023 |
000110465923118105 |
|
Q2 2023
|
24 |
401,432 |
ELVN, TRDA, IRON, RLYB
|
13F-HR
|
8/14/2023 |
000110465923091386 |
|
Q1 2023
|
24 |
391,037 |
ELVN, TRDA, VOR, RLYB
|
13F-HR
|
5/15/2023 |
000110465923060792 |
|
Q4 2022
|
21 |
372,119 |
CINC, TRDA, VOR, RLYB
|
13F-HR
|
2/14/2023 |
000110465923020417 |
|
Q3 2022
|
21 |
521,967 |
CINC, TRDA, RLYB, PEAR
|
13F-HR
|
11/14/2022 |
000110465922118475 |
|
Q2 2022
|
21 |
404,177 |
CINC, TRDA, VOR, PEAR
|
13F-HR
|
8/15/2022 |
000110465922091196 |
|
Q1 2022
|
19 |
457,812 |
PEAR, CINC, TRDA, VOR
|
13F-HR
|
5/16/2022 |
000110465922061252 |
|
Q4 2021
|
17 |
532,794 |
PEAR, TRDA, VOR, RLYB
|
13F-HR
|
2/3/2022 |
000110465922011125 |
|
Q3 2021
|
16 |
492,476 |
VOR, RLYB, AKOUOS INC, FIXX
|
13F-HR
|
11/15/2021 |
000110465921139190 |
|
Q2 2021
|
12 |
397,346 |
VOR, AKOUOS INC, IDYA, FIXX
|
13F-HR
|
8/16/2021 |
000110465921106376 |
|
Q1 2021
|
11 |
555,358 |
VOR, AKOUOS INC, FIXX, IDYA
|
13F-HR
|
5/17/2021 |
000110465921067238 |
|
Q4 2020
|
10 |
296,929 |
AKOUOS INC, FIXX, ARVN, CABA
|
13F-HR
|
2/16/2021 |
000110465921022611 |
|
Q3 2020
|
9 |
380,295 |
Akouos Inc., FIXX, APRE, IDYA
|
13F-HR
|
11/16/2020 |
000110465920125766 |
|
Q2 2020
|
9 |
456,625 |
Akouos Inc., APRE, FIXX, IDYA
|
13F-HR
|
8/5/2020 |
000110465920090815 |
|
Q1 2020
|
8 |
322,967 |
APRE, FIXX, ARVN, CRNX
|
13F-HR
|
4/29/2020 |
000110465920053335 |
|
Q4 2019
|
9 |
464,773 |
APRE, FIXX, CRNX, ARVN
|
13F-HR
|
2/5/2020 |
000110465920011269 |